Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
3SBio Inc
15303SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution. It also offers YISAIPU, the receptor fusion tumor necrosis factor inhibitor; Mandi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides MN709 Minoxidil Foam and Nalfuraphine hydrochloride tablets. Further, it provides trading, project management and consultation, technology, sports, financial, investment advisory, as well as manufactures medical devices; and offers agricultural services. The company has collaboration agreements with companies, such as Toray. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People's Republic of China. Address: No. 3 A1, Road 10, Shenyang, China
Analytics
Objectif de Cours de WallStreet
61.19 HKDRatio C/B
8.2162Rendement du dividende
4.32 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 1530
Analyse des dividendes 1530
Croissance des dividendes sur 5 ans
46 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
20 %Historique des dividendes 1530
Valorisation des titres 1530
financières 1530
Résultats | 2019 | Dynamique |